Assessment of Therapeutic Efficacy of Artemisinins Based Combination Therapy (ACT) against Plasmodium falciparum Malaria in Kano and Katsina States, Nigeria
DOI:
https://doi.org/10.47430/ujmr.1722.008Keywords:
ACTs,, malaria, Kano, Katsina, in vivo, Plasmodium falciparumAbstract
Artemisinin Based Combination Therapy (ACT) has been adopted in Africa as a means of improving the efficacy of malaria treatment and slowing the development of resistance. This study was conducted between Jan 2013 and December, 2014 to evaluate the therapeutic efficacy of different ACTS used in Kano and Katsina States, Nigeria in subjects with uncomplicated P. falciparum malaria. Malaria positive subjects were identified by rapid diagnostic test (malaria HRP2 Kit) and microscopic examination of Giemsa stained blood samples. A total of 652 malaria positive subjects of all ages with prescription of any of the 3 different ACTs (Artemether – lumefantrine (AL), Dihydroartemisinin – piperaquine (DHP) and Artesunate – amodiaquine (AA), were enrolled. Clinical and parasitological response of the subjects treated with the ACTs were evaluated using 28 – days follow up according to WHO protocol for therapeutic efficacy. Genotyping of pre treatment and post treatment blood spots were carried out using nested PCR of MSP2 genetic marker to differentiate new infection from recrudescence in subject with treatment failure. Out of 652 subjects enrolled, 227 (34.8%) completed the 28 – days follow – up. Patients treated with DHP had a significantly lower risk of recurrent parasitaemia due to new infection compared to patients treated with AL and AA (2.4% vs 8.4%, 2.4% vs 16%) at P < 0.005. The cure rates of the 3 – treatment arms were found to be 95%, 99% and 93% for AL, DHP and AA respectively with no significant difference in the risk of treatment failure due to recrudescence of the parasites (P> 0.05). The finding has thus indicated that all the ACTs are still efficacious in the treatment of uncomplicated malaria in the areas. Continued resistance monitoring is recommended as the use of ACTs is in the increase in Nigeria.
Downloads
References
Burkirwa, H., Yeka A., Kamya M. R., Talisuna A., Banek, K. (2006). Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. Plos Clin. Trials 1: 7
https://doi.org/10.1371/journal.pctr.0010007
Cheesbrough, M. (2000). District Laboratory Practice Manual in Tropical Countries Pp 235-245. Cambridge University press.
Dorsey, G., Staedke, S., Clark, T. D., Njama- Meya, D., Nzarubara, B., Maiteki- Sebuguzi, C., Dokomajilar, C., Kamya, M. R., Rosenthal, P. J. (2007). Combination therapy for uncomplicated falciparum malaria: A longitudinal randomized trial. Lancet 360 (9350): 2031 - 8.
https://doi.org/10.1001/jama.297.20.2210
Ezzet F., Mull, R. and Karbwang J. (1998). Population pharmacokinetics and therapeutic response of CGP 56697 (Artemether - Lumefantrine in Malaria Patients. Br. J. Clin. Pharmacol 46: 553 - 561.
https://doi.org/10.1046/j.1365-2125.1998.00830.x
Gupta, S., Thapar, M. M., Mariga, S. T., Wernsdorfer, W. H., and Bjorkman, A. (2002). Plasmodium falciparum: in vitro Interactions of artemisinin with amodiaquine, pyronaridine, and chloroquine. Experimental Parasitology, 100 (1): 28-35.
https://doi.org/10.1006/expr.2001.4659
Happi, C. T., Gbotosho, G., Folarin, O. A., Sowunmi, A., Hudson T., Neil M. O., Milhouse, W., Wirth, D.F. and Oduola, A. M. J. (2008). Selection of plasmodium falciparum mdr1 in asexual stages and gametocytes by artemether - lumefantrine in Nigerian children with uncomplicated falciparum malaria. J. Antimicrobial Agents and Chemotherapy 53 (3): 885 - 895.
https://doi.org/10.1128/AAC.00968-08
Holding, P. A. and Snow, R. W. (2001). Impacts of P. falciparum malaria on performance and learning: Review of the evidence. Med. Hyg. 64 (1-2supp).
https://doi.org/10.4269/ajtmh.2001.64.68
Humphrey, G. S., Merinopoulos, I., Ahmed, J., Whitty, C. J., Mutabingwa, T. K., Sutherland, C. J. and Hallet, R. L. (2007). Amodiquine and artermeter lumefantrine select distinct alleles of the Plasmodium falciparum mdrl gene in Tanzanian children treated for uncomplicated malaria. Antimicrob. Agents Chemother 51: 991 - 997. http://en.wikipedia.org/wikip/plasmodiu m-falciparum.
https://doi.org/10.1128/AAC.00875-06
Hung, T. Y., Davis T. M., Ilett K. F., Kawnajeewa H., Mawitt, S. (2004). Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria. Br. J. Clin. Pharmacol 57: 253 - 262.
https://doi.org/10.1046/j.1365-2125.2003.02004.x
Ikpa, T. F., Ajayi, J. A., Imandeh, G. N., and Usar, J. I. (2010). In vitro surveillance of drug resistant falciparum malaria in north central Nigeria. African Journal of Clinical and Experimental Microbiology, 11 (2): 111 - 119.
https://doi.org/10.4314/ajcem.v11i2.53917
Kaira, B. S., Chawla, S., Gupta, P., and Valencha, N. (2006). Screening of antimalarial drugs: an overview. Indian Journal of Pharmacology, 38: 5-12.
https://doi.org/10.4103/0253-7613.19846
Martensson, A., Stroberg, J., Sisowath, C., Msellem, M. I., Gil, J. P., Montgomery, S. M., Olliaro, P., Ali, A. S., and Bjorkman, A. (2005). Efficacy of artesunate plus amodiaquine versus that of artemether- lemefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clinical Infectious Diseases, 41: 1079-1086.
https://doi.org/10.1086/444460
Mugittu, K., Adjuik, M., Snounou, G., Ntoumi, F., Taylor, W., Mshinda, H., Olliaro, P., and Beck, H. P. (2006). Molecular genotyping to distinguish between recrudescent and new infections in treatment trials of P. falciparum malaria conducted in sub- saharan Africa. Trop. Med. Int. Health 11: 1350 - 1359.
https://doi.org/10.1111/j.1365-3156.2006.01688.x
Mutabingwa, T. K., Anthony, D., Heller, A., Hallet, R., Ahmed, J., Drakeley, C., Greenwood, B. M., and Whitty,C.J.(2005).Amodiaquine alone, amodiaquine/sulfadoxine-pyrimethamine, amodiaquine/artesunate, and arthemether/lumefantrine for out- patient treatment of malaria in Tanzanian children: a four arm randomized effectiveness trial. Lancet, 365 (9469): 1474-1480.
https://doi.org/10.1016/S0140-6736(05)66417-3
Piola, P., Fogg. C., Bajunirwe, F., Biraro, S., Grandesso, F., Ruzagira, E., Babigumira, J., Kigozi, I., Kigulli, J. M., Kyomuhendo J., and Guthman J. P. (2005). Supervised versus unsupervised intake of six-dose artemether lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara Uganda
https://doi.org/10.1016/S0140-6736(05)66416-1
a randomized trial. Lancet 2005, 365: 1467- 73.
Sinclair, D., Zani, B., Donegan, S. Olliaro, P., Garner, P. (2009). Artemisinin based combination therapy for treating uncomplicated malaria. Review1 (220) Cochrane Database syst rev. 8
https://doi.org/10.1002/14651858.CD007483.pub2
Sisowath, C. J., Stromberg, A., Martensson, M., Msellem, C., Obondo, A., Bjorkman, and Gil J. P. (2005).In vivo selection of Plasmodium falciparumPfmdr186N coding alleles by artemetherlumefantrine (co- artem). J. Infect. Dis. 191: 1014 - 1017.
https://doi.org/10.1086/427997
Snounou G., and Beck, H., (1998). The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Parasitol. Today 14: 462 - 467.
https://doi.org/10.1016/S0169-4758(98)01340-4
Snounou, G., Siripoon, N., Jarra, W., Thaithong, S., Brown, K. and Vinyakosol S., (1999). Biased distribution of MSP1 and MSP2 allelic variants in Plasmodium falciparum populations in Thailand. Transaction of the Royal Society of Tropical Medicine and Hygiene 93: 369 - 374.
https://doi.org/10.1016/S0035-9203(99)90120-7
Snounou, G., Viriyakosol, S., Jarra, W., Thaithong, S., and Brown, K., (1993). Identification of the four human malarial species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Molecular and Biochemical Parasitology, 58: 283-292.
https://doi.org/10.1016/0166-6851(93)90050-8
Song, J., Socheat, D., Tan, B., Seita, S., Xu, Y., Fengzhen, O. U., Sereng, S., Sophom, L., and Li, G. (2011). Randomized trials of artemisinin - piperaquine, dihydroartemisin - piperaquine phosphate and artemether - Lumefantrine for the treatment of multidrug resistant falciparum malaria in Cambodia Thailand border area. Malarial Journal 231 (10).
https://doi.org/10.1186/1475-2875-10-231
Sowunmi, A., Gbotosho, G. O., Happi, C. T., AdedejiA.A.,Fehintola F A ., Folarin O A., Tambo E and Fateye, B.A.( 2007). Therapeutic efficacy and effects of Arthemeterlumefantrine
andamodiaquine sulfa phyrimethamine on gametocyte carriage in children with uncomplicated plasmodium falciparum in south western Nigeria Am J Trop. Med. Hyg. 77:235-241.
https://doi.org/10.4269/ajtmh.2007.77.235
World Health Organization (1996). Assessment of the therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. WHO/MAL96.1077, Geneva.
World Health Organization.(2010).Guidelines for the treatment of malaria. WHO Press, Geneva, Switzerland.
World Health Organization. (2006). Guidelines for the treatment of malaria. WHO Press, Geneva, Switzerland.
Yeka, A., Dorsey G., Kamya, M. R., Talisuna, Lugemwa M., (2008). Artemeter- lumefantrine versus Dihydroartemisinin- piperaquine for treating uncomplicated malaria: A randomized clinical trials from four sites in Uganda. PLos One 3(6):e2390.doi.
https://doi.org/10.1371/journal.pone.0002390
Zongo, I., Dorsey, G., Rouamba N., Dokomajilar C., Sere Y., (2007). Randomized comparison of amodiaquine plus sulfadozine-pyrimethamine, artemether- lumefantrine, and dihydroartemisinin - piperaquine for the treatment of uncompleted Plasmodium falciparum malaria in Burkina Faso. Clin. Infect. Dis 45: 1453 - 1461.
https://doi.org/10.1086/522985
Zwang, J., Dorsey, G., Martensson, A., Alessandro, U., Ndiaye, J., Karema, C., Djimde, A., Philippe, B., Sodiomon, B. and Olliaro, P. (2014). Plasmodium falciparum clearance in clinical studies of artesunate amodiaquine and comparator treatments in sub-Saharan Africa. Malarial Journal 13: 114.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 UMYU Journal of Microbiology Research (UJMR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
